Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis
Authors:
- Chul-Hak YangCYChul-Hak Yang
- 1 August 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 321 (2) , 337-344
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education
This publication has 18 references indexed in Scilit:
- Inhibition of fos–jun–DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cellsCancer Letters, 1998
- Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell linesNutrition and Cancer, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Pharmacology ofCurcuma longaPlanta Medica, 1991
- Inhibition of angiogenesis by bleomycin and its copper complex.Chemical and Pharmaceutical Bulletin, 1990
- A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin FragmentScience, 1985
- Control of cell locomotion: perturbation with an antibody directed against specific glycoproteinsCell, 1985
- Protamine is an inhibitor of angiogenesisNature, 1982
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A synthesis of curcumin and related compoundsRecueil des Travaux Chimiques des Pays-Bas, 1964